Related Experiment Video
Updated: May 6, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
Percutaneous cervical cordotomy for managing refractory pain in a patient with a Pancoast tumor: A case report
Kuan-Yu Lu1, Feng-Sheng Lin2, Chia-Shiang Lin1,3
1Department of Anesthesiology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Background:
According to the World Health Organization analgesic ladder, cancer-related pain generally begins with pharmacotherapy in a stepwise approach. Nevertheless, some patients continue to experience poorly controlled pain despite medications, particularly when considering adverse effects and self-care quality. Percutaneous cervical cordotomy is an alternative interventional procedure for unremitting unilateral intractable cancer-related pain.
Case Summary:
The patient was diagnosed with lung cancer with destruction of the brachial plexus and ribs. For 2 mo, the patient experienced progressive severe weakness and pain in the right upper extremity. Notably, the pain intensity reached an extreme level, particularly when lying supine, even under heavy sedation. This heightened pain response posed a significant challenge; as a result, the patient was unable to undergo further evaluation through magnetic resonance imaging. Ultimately, he underwent percutaneous cervical cordotomy for symptom relief, resulting in complete resolution of right arm pain. After a 3-mo follow-up, the pain did not recur, and only a flurbiprofen local patch was required for mild scapular tightness.
Conclusion:
Cordotomy, under careful patient selection, appears to enhance the quality of life of patients with unilateral cancer-related pain.

